Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
SMSPHARMA.NS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q3.22
N/A
-0.24
vs NA
Q4.22
N/A
0.44
vs NA
Q1.23
N/A
0.41
vs NA
Q2.23
+173%
1.1
vs -1.51
Q3.23
N/A
NA
vs -0.24
Q4.23
+206%
1.36
vs 0.44
Q1.24
N/A
NA
vs 0.41
Q2.24
+52%
1.67
vs 1.1
Q3.24
N/A
2.15
vs NA
Q4.24
-100%
NA
vs 1.36
Sales Growth
YoY
Current
Estimates
Q3.22
-9%
1.6B vs 1.7B
Q4.22
+23%
1.5B vs 1.2B
Q1.23
+167%
1.5B vs 560.6M
Q2.23
+110%
1.4B vs 643.9M
Q3.23
+5%
1.7B vs 1.6B
Q4.23
+9%
1.6B vs 1.5B
Q1.24
+65%
2.5B vs 1.5B
Q2.24
+22%
1.6B vs 1.4B
Q3.24
+18%
2B vs 1.7B
Q4.24
+7%
1.7B vs 1.6B
Return on Equity
QoQ
Q1.23
+1%
0.01
vs 0.01
Q2.23
+2%
0.02
vs 0.01
Q3.23
+2%
0.02
vs 0.02
Q4.23
+2%
0.02
vs 0.02
Q1.24
+3%
0.03
vs 0.02
Q2.24
+3%
0.03
vs 0.03
Q3.24
+3%
0.03
vs 0.03
Q4.24
NA
NA
vs 0.03
Institutionnal Ownership
Relative Strength
SMSPHARMA.NS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Quote Panel
Key Metrics
Forecast
No Data Available
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, antiemetic, antiepileptic, antipsychotic, anti-hypertensive, anti-anginal, anti-viral, urinary antispasmodic, and anti-retroviral APIs. It is also involved in the contract research activities. The company also exports its products. SMS Pharmaceuticals Limited was incorporated in 1987 and is based in Hyderabad, India.
NSE
4.70Â ( 1.92%)
Pre-market NaN$0.00 (0.00%)
Relative Strenght
Volume Buzz
-75%
Earning Acce
No
Dist 52w H.
37%Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How SMSPHARMA.NS compares to sector?